India Endoscopy Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the India endoscopy devices market size is projected to expand from USD 1.49 billion in 2025 and USD 1.58 billion in 2026 to USD 2.17 billion by 2031, registering a CAGR of 6.56% between 2026 to 2031.

This report is Segmented by Type of Device (Endoscopes [Rigid Endoscope, and More], Endoscopic Operative Devices [Access Devices, and More], and Visualization Equipment), Application (Gastroenterology, Pulmonology, Cardiology, and More), End-User (Hospitals, Specialty Clinics, and More), Usage (Re-Usable Devices and Single-Use Devices). The Market Forecasts are Provided in Terms of Value (USD).

India Endoscopy Devices Market Trends and Insights

Rising Prevalence of Gastrointestinal Diseases

India carries the world's highest burden of enteric infections, and inflammatory bowel disease cases are projected to jump 69% from 270,000 in 2019 to 457,000 by 2050, expanding screening demand. Ayushman Bharat issued 420 million health cards to 33,000 hospitals by 2025, unlocking latent rural demand for upper and lower GI scopes. Tier-2 facilities now add day-care endoscopy suites that prefer flexible scopes over robotic platforms, aligning with cost ceilings. National cancer-control guidelines that mandate protocol-driven surveillance are also lengthening replacement cycles as high-volume sites seek durable, fast-reprocessing models.

Government Healthcare Expenditure & Insurance Expansion

Public health outlay rose from 0.9% of GDP in 2004 to 2.1% in 2023, and the FY25 Union Budget earmarked INR 9,406 crore (USD 1.13 billion) for Ayushman Bharat. PM-JAY's package-rate reimbursements for colonoscopy, ERCP, and polypectomy assure baseline volumes that de-risk hospital investment. Tamil Nadu's state insurance, integrated with PM-JAY, covers up to INR 500,000 per family member, stimulating private-sector endoscopy growth. North India, where bed density trails the south, is on track for 12-14% healthcare-delivery CAGR to FY28, translating into brisk device procurement. However, lower package prices pressure facilities to prefer reusable scopes unless outbreaks raise single-use uptake.

High Capital Cost of Advanced Endoscopy Systems

AI-ready 4K towers cost INR 15-25 million (USD 180,000-300,000). Robotic platforms such as Intuitive Surgical's da Vinci 5, deployed in 76 Indian installations by Q3 2024, demand multi-million-dollar budgets that most public facilities lack. State hospitals wrestle with staggered funding and delayed receivables, curbing big-ticket purchases despite tariff relief. Private hospitals mitigate risk through leasing and outcome-based service contracts, but these shift margin pressure onto vendors. Consequently, many buyers continue to favor durable, lower-spec reusable scopes over premium disposables even after the FTA price cut.

Other drivers and restraints analyzed in the detailed report include:

1. HD/4K, AI & Single-Use/Capsule Endoscopy Innovations
2. Expansion of Private Hospitals & ASCs
3. Shortage of Trained Endoscopists & Reprocessing Staff

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Visualization equipment revenue is projected to rise at an 8.55% CAGR from 2026-2031, surpassing endoscopes, which still held 61.62% of India endoscopy devices market share in 2025. The launch of Stryker's 1788 platform lets hospitals install 4K imaging and fluorescence without replacing entire scope fleets. Rigid endoscopes dominate ENT and orthopedic procedures, while flexible scopes remain foundational for GI and pulmonology. Capsule endoscopy serves remote-screening pilots, and robotic scopes remain a niche 76-unit installed base. Domestically, PLI-enabled assemblers can now import zero-duty optics post-FTA, helping them supply mid-range 4K towers to Tier-2 buyers.

Hospitals view visualization towers as a shared asset across specialties, generating quicker ROI than single-discipline robots. AI-enabled processors that overlay polyp-detection prompts raise adenoma-detection rates and drive upgrades. Advanced operative tools, such as Fujifilm's 360° Tracmotion ESD device, expand the therapeutic scope of demand. Net effect: visualization-first upgrades lengthen the life of reusable scopes, widening the installed base and unlocking recurring accessories revenue for suppliers.

Gastrointestinal procedures accounted for 44.13% of India's endoscopy devices market in 2025. Yet gynecology will post the fastest growth, with an 8.97% CAGR through 2031, as fertility clinics favor hysteroscopy and laparoscopy for PCOS and endometriosis. Laparoscopy remains the No. 2 application across bariatrics and oncology. Pulmonology growth is tied to the burden of COPD and the adoption of single-use bronchoscopes. ENT volumes pivot around functional endoscopic sinus surgery; urology benefits from aging demographics and rising prostate cancer diagnoses. Cardiology uses transesophageal scopes for structural heart interventions, but remains a niche.

Fertility-center expansion in Tier-2 hubs creates day-care throughput, rewarding mid-tier 4K systems with rapid instrument turnarounds. Package-rate reimbursements under PM-JAY also encourage gynecology units to adopt reusable hysteroscopes. Meanwhile, GI demand continues to surge thanks to aging, rising IBD, and new screening protocols. The dual-engine effect ensures diversified opportunities within the Indian endoscopy devices market.

Complete Report Scope:

• By Device Type
  • Endoscopes
    • Rigid Endoscopes
    • Flexible Endoscopes
    • Capsule Endoscopes
    • Robotic-assisted Endoscopes
  • Endoscopic Operative Devices
    • Irrigation / Suction Systems
    • Access Devices
    • Wound Protectors
    • Other Endoscopic Operative Devices
  • Visualization Equipment
• By Application
  • Gastrointestinal Endoscopy
  • Laparoscopy
  • Pulmonology / Bronchoscopy
  • ENT / Otolaryngology
  • Urology
  • Gynecology
  • Cardiology
  • Other Applications
• By Usability
  • Reusable Devices
  • Single-use / Disposable Devices
• By End-User
  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics

List of Companies Covered in this Report:

1. Ambu
2. Arthrex
3. B. Braun
4. Boston Scientific
5. Conmed
6. Cook Group
7. CapsoVision
8. FUJIFILM
9. HOYA
10. IntroMedic Co., Ltd.
11. Intuitive Surgical
12. Johnson & Johnson
13. Karl Storz
14. Medtronic
15. Olympus
16. Richard Wolf
17. Smiths Group
18. STERIS
19. Stryker

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support